Accéder au contenu
Merck
  • In vivo selection of reduced susceptibility to carbapenems in Acinetobacter baumannii related to ISAba1-mediated overexpression of the natural bla(OXA-66) oxacillinase gene.

In vivo selection of reduced susceptibility to carbapenems in Acinetobacter baumannii related to ISAba1-mediated overexpression of the natural bla(OXA-66) oxacillinase gene.

Antimicrobial agents and chemotherapy (2009-03-25)
Samy Figueiredo, Laurent Poirel, Jacques Croize, Christine Recule, Patrice Nordmann
RÉSUMÉ

Two clonally related Acinetobacter baumannii isolates, A1 and A2, were obtained from the same patient. Isolate A2, selected after an imipenem-containing treatment, showed reduced susceptibility to carbapenems. This resistance pattern was related to insertion of the ISAba1 element upstream of the naturally occurring bla(OXA-66) carbapenemase gene as demonstrated by sequencing, reverse transcription-PCR analysis, and inactivation of the bla(OXA-66) gene.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Rifampicine, ≥95% (HPLC), powder or crystals
Sigma-Aldrich
Rifampicine, suitable for plant cell culture, BioReagent, ≥95% (HPLC), powder or crystals